CR6797A - TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1) - Google Patents

TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1)

Info

Publication number
CR6797A
CR6797A CR6797A CR6797A CR6797A CR 6797 A CR6797 A CR 6797A CR 6797 A CR6797 A CR 6797A CR 6797 A CR6797 A CR 6797A CR 6797 A CR6797 A CR 6797A
Authority
CR
Costa Rica
Prior art keywords
nhe
inhibitor
sodium
type
hydrogen exchanger
Prior art date
Application number
CR6797A
Other languages
Spanish (es)
Inventor
George Chen Weichao
David Cox Eric
Guzman Perez Angel
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CR6797A publication Critical patent/CR6797A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN INHIBIDOR DE NHE-1 METODOS PARA UTILIZAR EL INHIBIDOR DE NHE-1 Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN EL INHIBIDOR DE NHE-1. EL INHIBIDOR DE NHE-1 ES UTIL PARA REDUCCION DE LAS LESIONES TISULARES RESULTANTES DE LA ISQUEMIA DE LOS TEJIDOS.AN NHE-1 INHIBITOR METHODS TO USE THE NHE-1 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE NHE-1 INHIBITOR. THE NHE-1 INHIBITOR IS USEFUL FOR REDUCING THE TISSULAR INJURIES RESULTING FROM THE TISSUE ISCHEMIA.

CR6797A 2000-04-28 2002-10-18 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1) CR6797A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
CR6797A true CR6797A (en) 2004-05-17

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6797A CR6797A (en) 2000-04-28 2002-10-18 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03006872A (en) * 2001-01-31 2003-11-13 Pfizer Prod Inc Ethanolates of sodium-hydrogen exchanger type-1 inhibitor.
CA2469305A1 (en) * 2001-12-19 2003-06-26 Frank Robert Busch Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
US7550480B2 (en) * 2003-02-14 2009-06-23 Smithkline Beecham Corporation Compounds
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056729B1 (en) * 1998-02-27 2004-12-29 Pfizer Products Inc. N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EA200201023A1 (en) 2003-02-27
MA26897A1 (en) 2004-12-20
YU79602A (en) 2006-05-25
ZA200208605B (en) 2003-10-24
OA12256A (en) 2003-11-06
AU2001235896A1 (en) 2001-11-12
UA73348C2 (en) 2005-07-15
GT200100064A (en) 2002-03-22
IL152075A0 (en) 2003-05-29
HRP20020851A2 (en) 2005-02-28
EP1276737A1 (en) 2003-01-22
TR200202439T2 (en) 2003-02-21
SK14872002A3 (en) 2004-03-02
UY26680A1 (en) 2001-12-28
CN1225466C (en) 2005-11-02
PA8513301A1 (en) 2003-09-05
NZ521348A (en) 2004-09-24
EE200200615A (en) 2004-04-15
HN2001000042A (en) 2001-07-09
BG107139A (en) 2003-07-31
DZ3310A1 (en) 2001-11-07
WO2001083470A1 (en) 2001-11-08
CZ20023408A3 (en) 2004-01-14
CA2407535A1 (en) 2001-11-08
CO5221125A1 (en) 2002-11-28
EA004882B1 (en) 2004-08-26
NO20025132L (en) 2002-12-12
AP2002002651A0 (en) 2002-12-31
AR028375A1 (en) 2003-05-07
IS6588A (en) 2002-10-21
MY133842A (en) 2007-11-30
JP2003531900A (en) 2003-10-28
BR0110268A (en) 2003-12-30
MXPA02010600A (en) 2003-03-10
PE20011270A1 (en) 2001-12-12
HUP0300651A2 (en) 2003-07-28
KR20020093079A (en) 2002-12-12
IS6567A (en) 2002-09-24
SV2002000418A (en) 2002-07-03
TNSN01065A1 (en) 2005-11-10
CN1426404A (en) 2003-06-25
PL357765A1 (en) 2004-07-26
NO20025132D0 (en) 2002-10-25

Similar Documents

Publication Publication Date Title
GT199900022A (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
GT199900150A (en) 1,2,3,4-TETRAHYDROQUINOLINS 2-SUBSTITUTED 4-CARBOXYAMIN SUBSTITUTED.
ECSP055747A (en) CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS
ES2145638T3 (en) NEW AZOIC COMPOUNDS, USE FOR STAINING, CONTAINING COMPOSITIONS AND STAINING PROCEDURES.
ES2157027T3 (en) OXAZOLIDINONES REPLACED AND ITS USE AS ANTIBACTERIAL PHARMACOS.
AR026052A1 (en) PURINA DERIVATIVES
HN2002000275A (en) DERIVATIVES OF 1.8 NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
MX9206991A (en) REFRIGERANT COMPOSITIONS AND PROCEDURES FOR USING THEM.
ES2175161T3 (en) PIPERAZINE DERIVATIVES AS TAQUIQUININE ANTAGONISTS.
MX9307232A (en) ARILCICLOALQUILAMINAS N, N-DISSTITUTED, ITS SALTS, MEDICINES CONTAINED IN THESE COMPOUNDS AND THEIR USE, AS WELL AS PROCEDURES FOR THEIR PREPARATION.
AR005431A1 (en) REACTIVE OZOCOLORANTS WITH COPULATION COMPONENTS OF THE SERIES OF AMINONAFTALENSULFONIC ACIDS, NAPHTHLAMINES USED AND INTERMEDIATED PRODUCTS, IN THE PREPARATION OF SUCH OZOCOLORANTS AND USE OF OZOCOLORANTS.
AR018162A1 (en) SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION
CR6797A (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1)
UY27203A1 (en) USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
AR030537A1 (en) ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS
ES2164765T3 (en) HETEROCICLILBENZONITRILOS.
GT199900113A (en) FKBP INHIBITORS.
ES2164151T3 (en) N- (INDOL-2-CARBON) GLICINAMIDES REPLACED AND DERIVED AS INHIBITORS OF GLOSSARY PHOSPHORILASE.
AR006675A1 (en) 4-BENZOILISOTIAZOLES HERBICIDES, PROCEDURE TO OBTAIN THEM, THE HERBICIDES COMPOSITIONS THAT CONTAIN THEM AND THE PROCEDURE OF APPLICATION OF SUCH COMPOUNDS.
ES2175661T3 (en) DERIVATIVES OF ISOFLAVONA, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
PA8505501A1 (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER CRYSTALS
ES2189108T3 (en) NEW DISPOSED OXAZINES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
UY26417A1 (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR CRYSTALS
ES2177308T3 (en) DERIVATIVES OF PHENYLETHYLAMINE, PROCEDURE FOR ITS PREPARATION AND ITS EMPLOYMENT AS MEDICINES.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)